A gene expression-based test identifies patients with primary cutaneous melanoma at a lower or higher risk for sentinel lymph ...

Get the latest analysis on Iovance Biotherapeutics (IOVA): dilution risks, missed revenue, and margin outlook. Click here to ...

Reports third quarter revenue of $1.0 billion, GAAP net loss of $(0.2) billion and GAAP EPS of $(0.51) Narrows 2025 projected ...

CytomX Therapeutics, Inc.'s ADC candidate, CX-2051, shows promise in colorectal cancer. Click here to read an analysis of ...

The 1970s gave us some beauty trends that were absolutely unforgivable. While only time will tell, we're hopeful that these ...

One in five people diagnosed with metastatic cancer in the Netherlands is still alive three years later, according to new ...

The percentage of patients with primary metastatic cancer who are still alive three years after their initial diagnosis is ...

Ex-President Joe Biden's frail appearance in a new video has critics claiming he looks 'absolutely lost'. Read the full ...

Scientists at the Peter Doherty Institute for Infection and Immunity (Doherty Institute) have uncovered how the gut ...

In terms of prognostic risk factors, HER2 positivity, BM surgical resection, and diagnosis after 2014 were associated with ...

Texas A&M scientists have unlocked new potential for astatine-211, a rare and short-lived element, as a highly precise cancer-fighting isotope. Its alpha emissions destroy tumor cells while sparing ...

The Swedish Cancer Society (Cancerfonden) has announced its research grants for 2025. Over SEK 90 million has been awarded to ...